Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Post-approval evidence generation: a shared responsibility for healthcare
Nature Medicine ( IF 58.7 ) Pub Date : 2024-09-13 , DOI: 10.1038/s41591-024-03241-x Ali Abbasi 1 , Donna Rivera 1 , Lesley H Curtis 1 , Robert M Califf 1
Nature Medicine ( IF 58.7 ) Pub Date : 2024-09-13 , DOI: 10.1038/s41591-024-03241-x Ali Abbasi 1 , Donna Rivera 1 , Lesley H Curtis 1 , Robert M Califf 1
Affiliation
|
Post-approval evidence generation is essential for high-quality clinical care and should be a shared priority for clinicians, health systems, payors, and the medical products industry, as well as the FDA and federal agencies.
中文翻译：
批准后证据生成：医疗保健的共同责任
批准后证据的生成对于高质量的临床护理至关重要，应成为临床医生、卫生系统、付款人和医疗产品行业以及 FDA 和联邦机构的共同优先事项。
更新日期：2024-09-13
中文翻译：
批准后证据生成：医疗保健的共同责任
批准后证据的生成对于高质量的临床护理至关重要，应成为临床医生、卫生系统、付款人和医疗产品行业以及 FDA 和联邦机构的共同优先事项。
京公网安备 11010802027423号